R3VIVE.ME MOTS-C 30mg is a research-grade mitochondrial-derived peptide formulation developed for laboratory studies involving metabolic regulation, mitochondrial signalling pathways, and cellular energy-response observation.

MOTS-C is a 16-amino acid mitochondrial-derived peptide (MDP) encoded by the MT-RNR1 gene and is frequently examined in controlled research environments for its role in metabolic adaptation and mitochondrial function studies.

This peptide is commonly referenced in laboratory research involving endurance modelling, energy-utilisation analysis, glucose-response pathways, and advanced metabolic signalling observation.

The research-grade formulation is stabilised and designed for scientific and laboratory applications only.

Key Features

• Mitochondrial-derived peptide formulation
• Examined for metabolic and energy pathway research
• Suitable for mitochondrial signalling studies
• Referenced in endurance and recovery modelling
• Research-grade peptide formulation

How to Use (Research Reference Only)

Research literature evaluates MOTS-C using structured peptide protocols within controlled laboratory environments.

This information is provided strictly for scientific context and is not guidance for human use.

Stacking (Research Context)

In laboratory environments, MOTS-C may be examined alongside:

• NAD+ metabolic pathway studies
• Recovery peptide formulations
• Endurance and mitochondrial research compounds

Stacking depends entirely on research objectives.

Research Disclaimer

For laboratory and scientific research use only.
Not intended for human consumption, medical treatment, or veterinary application.

What is MOTS-C? ( R3VIVE.ME MOTS-C 30mg )

MOTS-C is a mitochondrial-derived peptide studied in laboratory environments for metabolic adaptation, mitochondrial signalling, cellular energy regulation, and endurance-focused peptide research.